amlodipine has been researched along with Cardiomyopathy, Congestive in 8 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We randomly assigned 1153 patients with severe chronic heart failure and ejection fractions of less than 30 percent to double-blind treatment with either placebo (582 patients) or amlodipine (571 patients) for 6 to 33 months, while their usual therapy was continued." | 9.08 | Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. ( Belkin, RN; Carson, PE; Cropp, AB; DeMets, DL; Frid, D; Ghali, JK; Miller, AB; Neuberg, GW; O'Connor, CM; Packer, M; Pressler, ML; Wertheimer, JH, 1996) |
| "We randomly assigned 1153 patients with severe chronic heart failure and ejection fractions of less than 30 percent to double-blind treatment with either placebo (582 patients) or amlodipine (571 patients) for 6 to 33 months, while their usual therapy was continued." | 5.08 | Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. ( Belkin, RN; Carson, PE; Cropp, AB; DeMets, DL; Frid, D; Ghali, JK; Miller, AB; Neuberg, GW; O'Connor, CM; Packer, M; Pressler, ML; Wertheimer, JH, 1996) |
| "The prognosis of dilated cardiomyopathy(DCM) has improved due to advances in earlier diagnosis and therapy, however, sudden cardiac death and death from congestive heart failure still occur in DCM." | 2.41 | [Prognosis of hypertrophic and dilated cardiomyopathy]. ( Ikeda, H; Imaizumi, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steffen, HM | 1 |
| Packer, M | 1 |
| O'Connor, CM | 1 |
| Ghali, JK | 1 |
| Pressler, ML | 1 |
| Carson, PE | 1 |
| Belkin, RN | 1 |
| Miller, AB | 1 |
| Neuberg, GW | 1 |
| Frid, D | 1 |
| Wertheimer, JH | 1 |
| Cropp, AB | 1 |
| DeMets, DL | 1 |
| Poole-Wilson, PA | 1 |
| Kumamoto, H | 1 |
| Okamoto, H | 1 |
| Watanabe, M | 1 |
| Onozuka, H | 1 |
| Yoneya, K | 1 |
| Nakagawa, I | 1 |
| Chiba, S | 1 |
| Watanabe, S | 1 |
| Mikami, T | 1 |
| Abe, K | 1 |
| Kitabatake, A | 1 |
| Liu, PP | 1 |
| Mak, S | 1 |
| Stewart, DJ | 1 |
| Ikeda, H | 1 |
| Imaizumi, T | 1 |
| Yamada, S | 1 |
| Urayama, A | 1 |
| Kimura, R | 1 |
| Watanabe, H | 1 |
| Ohashi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regional and Systemic Hemodynamic Effects of a Long-term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin[NCT00151619] | Phase 2 | 7 participants (Actual) | Interventional | 1999-02-10 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amlodipine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Potential role of the microvasculature in progression of heart failure.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cardiomyopathy, Dilated; Coronary Vessels; Disease Mo | 1999 |
[Prognosis of hypertrophic and dilated cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel B | 2000 |
3 trials available for amlodipine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
[Amlodipine in heart failure: initial results of the PRAISE study].
Topics: Amlodipine; Calcium Channel Blockers; Cardiomyopathy, Dilated; Coronary Disease; Double-Blind Method | 1995 |
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Cardiomyopathy, Dilated; Chronic Disease; Double-Blind M | 1996 |
[Calcium antagonist in heart failure. No improvement, no damage].
Topics: Amlodipine; Calcium Channel Blockers; Cardiomyopathy, Dilated; Heart Failure; Humans; Survival Rate; | 2000 |
3 other studies available for amlodipine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Amlodipine in chronic heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Cardiomyopathy, Dilated; Chronic Disease; Coronary Angiography | 1997 |
Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Capillaries; Cardiomyopathy, Dilated; Cardiotonic Age | 1999 |
Ameliorating effects of amlodipine on plasma and myocardial catecholamines in BIO 53.58 Syrian hamsters, a model of dilated cardiomyopathy.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cardiomyopathy, Dilated; Catecholamines; Cricetinae; | 2000 |